Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Pulmonary Hypertension, August 2019

Free Subscription


Abstracts

Retrieve all available abstracts of the following 91 articles:
HTML format


 

Single Articles

  1. CHENG Y, Tung CK, Chung AKK, Liu WW, et al
    Screening Of Pulmonary Hypertension in Methamphetamine Abusers (SOPHMA): rationale and design of a multicentre, cross-sectional study.
    BMJ Open. 2019;9:e027193.
    Abstract    

    Abstract available

  2. OROZCO-HERNANDEZ EJ, Argueta-Sosa EE, Mauchley D, Xie R, et al
    Left ventricular myxoma: A contractile mass causing intracavitary obstruction and severe pulmonary hypertension.
    J Card Surg. 2019 Aug 2. doi: 10.1111/jocs.14195.
    Abstract    

    Abstract available

  3. SAKURAI K, Fujiwara N, Takahashi K, Nakayashiro M, et al
    Excessive soft drink may induce pulmonary hypertension via thiamine deficiency.
    Pediatr Int. 2019 Aug 1. doi: 10.1111/ped.13913.
    Abstract    



  4. MCSWEENEY J, Rosenholm E, Penny K, Mullen MP, et al
    Improving Safety of Intravenous Prostacyclin Administration to Pediatric Patients With Pulmonary Hypertension.
    Crit Care Nurse. 2019;39:e1-e7.
    Abstract    

    Abstract available

  5. LEARY PJ, Lahm T, Melendres-Groves L, Reddy A, et al
    Which Needle in Which Haystack? Multisystem Care for Pulmonary Hypertension Patients.
    Ann Am Thorac Soc. 2019;16:979-981.
    Abstract    



  6. VILLAQUIRAN C, Moreno S, Duenas R, Acuna P, et al
    Cross-cultural adaptation of the Cambridge Pulmonary Hypertension Outcome Review for use in patients with pulmonary hypertension in Colombia.
    J Bras Pneumol. 2019;45:e20180332.
    Abstract    

    Abstract available

  7. ANDRADE FM, Oliveira AD, Lopes AJ
    Ventilation distribution as a contributor to the functional exercise capacity in patients with systemic sclerosis-associated interstitial lung disease without pulmonary hypertension.
    Braz J Med Biol Res. 2019;52:e8513.
    Abstract    

    Abstract available

  8. CHAN IP, Weng MC, Hsueh T, Lin YC, et al
    Prognostic value of right pulmonary artery distensibility in dogs with pulmonary hypertension.
    J Vet Sci. 2019;20:e34.
    Abstract    

    Abstract available

  9. HECIMOVIC A, Heaney A, McKenna SP, Basara L, et al
    ADAPTATION AND VALIDATION OF THE CAMBRIDGE PULMONARY HYPERTENSION OUTCOME REVIEW (CAMPHOR) FOR CROATIA.
    Acta Clin Croat. 2019;58:3-12.
    Abstract    

    Abstract available

  10. BUI CB, Kolodziej M, Lamanna E, Elgass K, et al
    Interleukin-1 Receptor Antagonist Protects Newborn Mice Against Pulmonary Hypertension.
    Front Immunol. 2019;10:1480.
    Abstract    

    Abstract available

  11. JI L, Wu W, Sun Z, Wang B, et al
    Acute Pulmonary Hypertension During Pregnancy Caused by Isolated Cor Triatriatum Sinus With Left Atrial Thrombus.
    Circ Cardiovasc Imaging. 2019;12:e009331.
    Abstract    



  12. ALROSSAIS NM, Alshammari AM, Alrayes AM, Mohammad N, et al
    Pulmonary Hypertension and Polycythemia Secondary to Pulmonary Alveolar Microlithiasis Treated with Sequential Bilateral Lung Transplant: A Case Study and Literature Review.
    Am J Case Rep. 2019;20:1114-1119.
    Abstract    

    Abstract available

  13. ALI N, Clarke L, MacKenzie Ross RV, Robinson G, et al
    Pulmonary vasculitis mimicking chronic thromboembolic disease.
    BMJ Case Rep. 2019;12.
    Abstract    

    Abstract available

  14. HUNG CF, Wilson CL, Schnapp LM
    Pericytes in the Lung.
    Adv Exp Med Biol. 2019;1122:41-58.
    Abstract    

    Abstract available

  15. MARCHAND E, d'Odemont JP, Dupont MV
    A Patient with GOLD Stage 3 COPD << cured >> by One-Way Endobronchial Valves.
    Medicina (Kaunas). 2019;55.
    Abstract    

    Abstract available

  16. GUIMARAES L, Lindenfeld J, Sandoval J, Bayes-Genis A, et al
    Interatrial shunting for heart failure: current evidence and future perspectives.
    EuroIntervention. 2019;15:164-171.
    Abstract    

    Abstract available

  17. FAN Y, Zhao J, Qian J, Hao Y, et al
    Cysteine-rich protein 61 as a novel biomarker in systemic lupus erythematosus-associated pulmonary arterial hypertension.
    Clin Exp Rheumatol. 2019;37:623-632.
    Abstract    

    Abstract available

  18. SU J, Hughes AD, Simonsen U, Howard LS, et al
    Nitric Oxide Attenuates Arterial Pulse Wave Reflection in a Vasodilator Responding Pulmonary Arterial Hypertension Patient.
    Circ Cardiovasc Interv. 2018;11:e006242.
    Abstract    



  19. HUIS IN 'T VELD AE, Oosterveer FPT, De Man FS, Marcus JT, et al
    Hemodynamic effects of PAH-specific therapy in patients with HFpEF with combined post- and pre-capillary pulmonary hypertension.
    J Card Fail. 2019 Aug 5. pii: S1071-9164(18)31294.
    Abstract    

    Abstract available

  20. SONAGLIONI A, Lombardo M, Rigamonti E, Vincenti A, et al
    Unusual presentation of acute pulmonary hypertension in a patient with bilateral pneumonia and hypertrophic cardiomyopathy.
    J Cardiovasc Med (Hagerstown). 2019 Aug 5. doi: 10.2459/JCM.0000000000000848.
    Abstract    

    Abstract available

  21. ZHANG W
    Comments on 'Pulmonary hypertension could be a risk for deep vein thrombus in lower extremities after joint replacement surgery'.
    Rev Assoc Med Bras (1992). 2019;65:951.
    Abstract    



  22. REXITI P, Wutiku M, Wulamu W, Bai F, et al
    Pulmonary hypertension could be a risk for deep vein thrombosis in lower extremities after joint replacement surgery.
    Rev Assoc Med Bras (1992). 2019;65:946-950.
    Abstract    

    Abstract available

  23. LI M, Cai W, Chen Y, Dong L, et al
    The CAV1 Gene 3' Untranslated Region Single Nucleotide Polymorphisms Are Associated with the Risk of Pulmonary Hypertension in Chinese Han Chronic Obstructive Pulmonary Patients.
    Genet Test Mol Biomarkers. 2019 Aug 6. doi: 10.1089/gtmb.2019.0053.
    Abstract    

    Abstract available

  24. CIRULIS MM, Jorgensen LO, Day RW
    Acute vasodilator testing: An opportunity to advance the precision care of pulmonary hypertension.
    Respir Med Case Rep. 2019;28:100911.
    Abstract    

    Abstract available

  25. PETROV I, Tasheva I, Stankov Z, Polomski P, et al
    Uneventful Follow-Up 2 Years after Endovascular Treatment of a High-Flow Iatrogenic Aortocaval Fistula Causing Pulmonary Hypertension and Right Heart Failure.
    Methodist Debakey Cardiovasc J. 2019;15:152-155.
    Abstract    

    Abstract available

  26. PRASAD K
    AGE-RAGE Stress in the Pathophysiology of Pulmonary Hypertension and its Treatment.
    Int J Angiol. 2019;28:71-79.
    Abstract    

    Abstract available

  27. CARAVACA PEREZ P, Galvan Roman F, Escribano Subias P
    Inverse cardiac tamponade in severe pulmonary hypertension.
    Med Clin (Barc). 2019 Aug 2. pii: S0025-7753(19)30425.
    Abstract    



  28. VIENTOS-PLOTTS AI, Wiggen KE, Lisciandro GR, Reinero CR, et al
    The utility of point-of-care ultrasound right-sided cardiac markers as a screening test for moderate to severe pulmonary hypertension in dogs.
    Vet J. 2019;250:6-13.
    Abstract    

    Abstract available

  29. LIU X, Mei M, Chen X, Lu Y, et al
    Identification of genetic factors underlying persistent pulmonary hypertension of newborns in a cohort of Chinese neonates.
    Respir Res. 2019;20:174.
    Abstract    

    Abstract available

  30. CASSADY SJ, Reed RM
    Pulmonary Hypertension in COPD: A Case Study and Review of the Literature.
    Medicina (Kaunas). 2019;55.
    Abstract    

    Abstract available

  31. YANG J, Liu C, Li L, Tu X, et al
    Red Blood Cell Distribution Width Predicts Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease.
    Can Respir J. 2019;2019:3853454.
    Abstract    

    Abstract available

  32. ZHANG LL, Zhang J
    [Analysis of hemodynamics and outcomes of pregnant women with congenital heart disease-pulmonary arterial hypertension].
    Zhonghua Fu Chan Ke Za Zhi. 2019;54:438-444.
    Abstract    

    Abstract available

  33. CORDA A, Carta S, Varcasia A, Tamponi C, et al
    Pulmonary arterial response to Angiostrongylus vasorum in naturally infected dogs: echocardiographic findings in two cases.
    Parasit Vectors. 2019;12:286.
    Abstract    

    Abstract available

  34. QIAN K, Yang N, Lin C, Wan H, et al
    Portopulmonary hypertension: A complex case derived from multiple penetrating trauma-induced mesentereic arteriovenous fistulae.
    Ann Vasc Surg. 2019 Feb 22. pii: S0890-5096(19)30156.
    Abstract    

    Abstract available

  35. WIELOCH R, Sipahi NF, Boeken U, Albert A, et al
    Ventricular assist device in a patient with congenitally corrected transposition of the great arteries and situs inversus totalis.
    Int J Artif Organs. 2019;42:321-322.
    Abstract    

    Abstract available

  36. RODRIGUEZ-BLANCO S, Oulego-Erroz I, Alonso-Quintela P, Terroba-Seara S, et al
    N-terminal-probrain natriuretic peptide as a biomarker of moderate to severe bronchopulmonary dysplasia in preterm infants: A prospective observational study.
    Pediatr Pulmonol. 2018 May 23. doi: 10.1002/ppul.24053.
    Abstract    

    Abstract available

  37. DUIN RWBV, Stam K, Uitterdijk A, Bartelds B, et al
    Intervening with the Nitric Oxide Pathway to Alleviate Pulmonary Hypertension in Pulmonary Vein Stenosis.
    J Clin Med. 2019;8.
    Abstract    

    Abstract available

  38. ROELS E, Merveille AC, Moyse E, Gomart S, et al
    Diagnostic value of the pulmonary vein-to-right pulmonary artery ratio in dogs with pulmonary hypertension of precapillary origin.
    J Vet Cardiol. 2019;24:85-94.
    Abstract    

    Abstract available

  39. JAFFEY JA, Leach SB, Kong LR, Wiggen KE, et al
    Clinical efficacy of tadalafil compared to sildenafil in treatment of moderate to severe canine pulmonary hypertension: a pilot study.
    J Vet Cardiol. 2019;24:7-19.
    Abstract    

    Abstract available

  40. SHIN YR, Yang YH, Park YH, Park HK, et al
    Emergency Pulmonary Artery-to-Systemic Artery Shunt to Break the Positive Feedback Loop of a Pulmonary Hypertensive Crisis after Neonatal Coarctation Repair.
    Korean J Thorac Cardiovasc Surg. 2019;52:232-235.
    Abstract    

    Abstract available

  41. SHAH TG, Sutaria JM, Vyas MV
    The association between pulmonary hypertension and stroke: A systematic review and meta-analysis.
    Int J Cardiol. 2019 Jul 31. pii: S0167-5273(19)31075.
    Abstract    

    Abstract available

  42. O'BRIEN J, Jones N, Horrigan M, Al-Kaisey AM, et al
    Rare cause of pulmonary hypertension - pulmonary tumour thrombotic microangiopathy.
    BMJ Case Rep. 2019;12.
    Abstract    

    Abstract available

  43. STEURER MA, Baer RJ, Oltman S, Ryckman KK, et al
    Morbidity of Persistent Pulmonary Hypertension of the Newborn in the First Year of Life.
    J Pediatr. 2019 Aug 6. pii: S0022-3476(19)30817.
    Abstract    

    Abstract available

  44. HUSSEIN MIH
    Pulmonary Hypertension as a Primary Presentation for Schistosomiasis, a Case Report of Unusual Presentation.
    Oxf Med Case Reports. 2019;2019.
    Abstract    

    Abstract available

  45. KOZAWA S, Nata M
    Sudden death of a preschool child diagnosed by postmortem examination.
    J Forensic Leg Med. 2019;66:144-146.
    Abstract    

    Abstract available

  46. HIRASHIKI A, Adachi S, Okumura N, Nakano Y, et al
    Medium-term health-related quality of life in patients with pulmonary arterial hypertension treated with goal-oriented sequential combination therapy based on exercise capacity.
    Health Qual Life Outcomes. 2019;17:103.
    Abstract    

    Abstract available

  47. RAJIAH P, Tanabe Y, Partovi S, Moore A, et al
    State of the art: utility of multi-energy CT in the evaluation of pulmonary vasculature.
    Int J Cardiovasc Imaging. 2019;35:1509-1524.
    Abstract    

    Abstract available

  48. FOWLER ED, Hauton D, Boyle J, Egginton S, et al
    Energy Metabolism in the Failing Right Ventricle: Limitations of Oxygen Delivery and the Creatine Kinase System.
    Int J Mol Sci. 2019;20.
    Abstract    

    Abstract available

  49. TEYMOURI RAD R, Dadashzadeh S, Vatanara A, Alavi S, et al
    Tadalafil nanocomposites as a dry powder formulation for inhalation, a new strategy for pulmonary arterial hypertension treatment.
    Eur J Pharm Sci. 2019;133:275-286.
    Abstract    

    Abstract available

  50. GESSLER T
    lloprost delivered via the BREELIB(TM) nebulizer: a review of the clinical evidence for efficacy and safety.
    Ther Adv Respir Dis. 2019;13:1753466619835497.
    Abstract    

    Abstract available

  51. BELGE C, Delcroix M
    Treatment of pulmonary arterial hypertension with the dual endothelin receptor antagonist macitentan: clinical evidence and experience.
    Ther Adv Respir Dis. 2019;13:1753466618823440.
    Abstract    

    Abstract available

  52. TOYA T, Nagatomo Y, Kagami K, Yukino M, et al
    Computed tomography-measured pulmonary artery to aorta ratio and EUTOS score for detecting dasatinib-induced pulmonary arterial hypertension.
    Int J Cardiovasc Imaging. 2019;35:1435-1442.
    Abstract    

    Abstract available

  53. TAKEI M, Kawakami T, Kataoka M, Kuwahira I, et al
    Residual high intrapulmonary shunt fraction limits exercise capacity in patients treated with balloon pulmonary angioplasty.
    Heart Vessels. 2019;34:868-874.
    Abstract    

    Abstract available

  54. ASHEK A, Spruijt OA, Harms HJ, Lammertsma AA, et al
    3'-Deoxy-3'-[18F]Fluorothymidine Positron Emission Tomography Depicts Heterogeneous Proliferation Pathology in Idiopathic Pulmonary Arterial Hypertension Patient Lung.
    Circ Cardiovasc Imaging. 2018;11:e007402.
    Abstract    

    Abstract available

  55. MIYAUCHI T, Sakai S
    Endothelin and the heart in health and diseases.
    Peptides. 2019;111:77-88.
    Abstract    

    Abstract available

  56. CIFTCI O, Unal EN, Dellaloglu Z, Aydan A, et al
    Relationship Between Preoperative Diastolic Transpulmonary Gradient With Pulmonary Vascular Resistance and 1-Year and Overall Mortality Rates Among Patients Undergoing Cardiac Transplant.
    Exp Clin Transplant. 2019;17:231-235.
    Abstract    

    Abstract available

  57. CHAUDHRY MA, Johnson A, Heywood JT
    Stiff Left Atrial Syndrome; Prospects and Possibilities. Retrospective Analysis and Review of the Literature.
    Curr Hypertens Rev. 2019;15:17-21.
    Abstract    

    Abstract available

  58. RUSSO FM, Conings S, Allegaert K, van Mieghem T, et al
    Sildenafil crosses the placenta at therapeutic levels in a dually perfused human cotyledon model.
    Am J Obstet Gynecol. 2018 Sep 4. pii: S0002-9378(18)30720.
    Abstract    

    Abstract available

  59. MARTENS T, Kostolny M, Spencer H, Muthialu N, et al
    Technical challenges of lung transplantation in children after arterial switch operation.
    Interact Cardiovasc Thorac Surg. 2019;28:493-495.
    Abstract    

    Abstract available

  60. XU S, Yang J, Zhu Y, Xu S, et al
    CTPA, DECT, MRI, V/Q Scan, and SPECT/CT V/Q for the noninvasive diagnosis of chronic thromboembolic pulmonary hypertension: A protocol for systemic review and network meta-analysis of diagnostic test accuracy.
    Medicine (Baltimore). 2019;98:e16787.
    Abstract    

    Abstract available

  61. BANDORSKI D, Holtgen R, Ghofrani A, Johnson V, et al
    [Arrhythmias in patients with pulmonary hypertension and chronic lung disease].
    Herzschrittmacherther Elektrophysiol. 2019.
    Abstract    

    Abstract available

  62. TAHARA M, Oda K, Yamasaki K, Kawaguchi T, et al
    Temporal echocardiographic assessment of pulmonary hypertension in idiopathic pulmonary fibrosis patients treated with nintedanib with or without oxygen therapy.
    BMC Pulm Med. 2019;19:157.
    Abstract    

    Abstract available

  63. CORREALE M, Tricarico L, Padovano G, Ferraretti A, et al
    Echocardiographic score for prediction of pulmonary hypertension at catheterization: the Daunia Heart Failure Registry.
    J Cardiovasc Med (Hagerstown). 2019 Aug 20. doi: 10.2459/JCM.0000000000000853.
    Abstract    

    Abstract available

  64. SPIESSHOEFER J, Herkenrath S, Mohr M, Randerath W, et al
    Diaphragm Function Does Not Independently Predict Exercise Intolerance in Patients with Precapillary Pulmonary Hypertension After Adjustment for Right Ventricular Function.
    Biosci Rep. 2019 Aug 19. pii: BSR20190392. doi: 10.1042/BSR20190392.
    Abstract    

    Abstract available

  65. MINATSUKI S, Kiyosue A, Kodera S, Hara T, et al
    Effectiveness of balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension despite having lesion types suitable for surgical treatment.
    J Cardiol. 2019 Aug 16. pii: S0914-5087(19)30221.
    Abstract    

    Abstract available

  66. NILSSON KF, Gozdzik W, Zielinski S, Ratajczak K, et al
    Pulmonary Vasodilation by Intravenous Infusion of Organic Mononitrites of 1,2-Propanediol in Acute Pulmonary Hypertension Induced by Aortic Cross Clamping and Reperfusion: A Comparison with Nitroglycerin in Anesthetised Pigs.
    Shock. 2019 Aug 14. doi: 10.1097/SHK.0000000000001436.
    Abstract    

    Abstract available

  67. ABE N, Kato M, Kono M, Fujieda Y, et al
    Right ventricular dimension index by cardiac magnetic resonance for prognostication in connective tissue diseases and pulmonary hypertension.
    Rheumatology (Oxford). 2019 Aug 19. pii: 5551402.
    Abstract    

    Abstract available

  68. WAZIRI F, Mellemkjaer S, Clemmensen TS, Hjortdal VE, et al
    Long-term changes of resting and exercise right ventricular systolic performance in patients with chronic thromboembolic pulmonary hypertension following pulmonary thromboendarterectomy - A two-dimensional and three-dimensional echocardiographic study
    Echocardiography. 2019 Aug 19. doi: 10.1111/echo.14456.
    Abstract    

    Abstract available

  69. SAKAO S, Tanabe N, Tatsumi K
    Hypoxic Pulmonary Vasoconstriction and the Diffusing Capacity in Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis.
    J Am Heart Assoc. 2019;8:e013310.
    Abstract    



  70. HALVANI A, Haddad H
    Comparison of the Factors Influencing Pulmonary Arterial Pressure in Smoker and Non-smoker COPD Patients with Pulmonary Hypertension.
    Tanaffos. 2019;18:41-46.
    Abstract    

    Abstract available

  71. SEYYEDI SR, Sharif-Kashani B, Sadr M, Chitsazan M, et al
    The Relationship between Electrocardiographic Changes and Prognostic Factors in Severely Symptomatic Pulmonary Hypertension.
    Tanaffos. 2019;18:34-40.
    Abstract    

    Abstract available

  72. KUSUNOSE K, Yamada H, Nishio S, Hirata Y, et al
    Pulmonary Artery Hypertension-Specific Therapy Improves Exercise Tolerance and Outcomes in Exercise-Induced Pulmonary Hypertension.
    JACC Cardiovasc Imaging. 2019 Aug 8. pii: S1936-878X(19)30622.
    Abstract    



  73. YANG L, Liang H, Shen L, Guan Z, et al
    LncRNA Tug1 involves in the pulmonary vascular remodeling in mice with hypoxic pulmonary hypertension via the microRNA-374c-mediated Foxc1.
    Life Sci. 2019 Aug 15:116769. doi: 10.1016/j.lfs.2019.116769.
    Abstract    

    Abstract available

  74. VENTON G, Turcanu M, Colle J, Thuny F, et al
    Pulmonary hypertension in patients with myeloproliferative neoplasms: A large cohort of 183 patients.
    Eur J Intern Med. 2019 Aug 14. pii: S0953-6205(19)30275.
    Abstract    

    Abstract available

  75. NAUMBURG E, Soderstrom L
    Increased risk of pulmonary hypertension following premature birth.
    BMC Pediatr. 2019;19:288.
    Abstract    

    Abstract available

  76. NATHAN SD, Behr J, Collard HR, Cottin V, et al
    Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study.
    Lancet Respir Med. 2019 Aug 12. pii: S2213-2600(19)30250.
    Abstract    

    Abstract available

  77. MEYER KC
    Pulmonary hypertension associated with idiopathic interstitial pneumonia: is effective pharmacotherapy an impossible dream?
    Lancet Respir Med. 2019 Aug 12. pii: S2213-2600(19)30266.
    Abstract    



  78. ANDERSON C, Hillman NH
    Bronchopulmonary Dysplasia: When the Very Preterm Baby Comes Home.
    Mo Med. 2019;116:117-122.
    Abstract    

    Abstract available

  79. ZENG ZH, Wu WH, Peng Q, Sun YH, et al
    MicroRNA132 mediates proliferation and migration of pulmonary smooth muscle cells via targeting PTEN.
    Mol Med Rep. 2019;19:3823-3830.
    Abstract    

    Abstract available

  80. GROTTI S, Dall'Ara G, Tarantino F, Bachetti C, et al
    Cardiac Arrest in a 31-Year-Old Man With Noonan Syndrome.
    J Invasive Cardiol. 2019;31:E40.
    Abstract    

    Abstract available

  81. MOKRA D, Mokry J, Matasova K
    Phosphodiesterase inhibitors: Potential role in the respiratory distress of neonates.
    Pediatr Pulmonol. 2018 Jun 15. doi: 10.1002/ppul.24082.
    Abstract    

    Abstract available

  82. CAI Z, van Duin RWB, Stam K, Uitterdijk A, et al
    Right Ventricular Oxygen Delivery as a Determinant of Right Ventricular Functional Reserve during Exercise in Juvenile Swine with Chronic Pulmonary Hypertension.
    Am J Physiol Heart Circ Physiol. 2019 Aug 9. doi: 10.1152/ajpheart.00130.2019.
    Abstract    

    Abstract available

  83. OLIVEIRA AC, Fu C, Lu Y, Williams MA, et al
    Chemokine signaling axis between endothelial and myeloid cells regulates development of pulmonary hypertension associated with pulmonary fibrosis and hypoxia.
    Am J Physiol Lung Cell Mol Physiol. 2019 Jul 31. doi: 10.1152/ajplung.00156.2019
    Abstract    

    Abstract available

  84. GEORGE PM, Mitchell J
    Defining a pathological role for the vasculature in the development of fibrosis and pulmonary hypertension in interstitial lung disease.
    Am J Physiol Lung Cell Mol Physiol. 2019 Aug 21. doi: 10.1152/ajplung.00330.2019
    Abstract    



  85. FRIGAULT J, Lafreniere-Bessi V, Perron J, Bedard E, et al
    Anomalous Left Coronary Artery from the Pulmonary Artery: Masquerading as Peripartum Cardiomyopathy.
    Ann Thorac Surg. 2018 Mar 9. pii: S0003-4975(18)30324.
    Abstract    

    Abstract available

  86. URBAN M, Booth K, O'Sullivan J, Dark J, et al
    Novel Management of Atrial Septal Defect at Time of Lung Transplantation.
    Ann Thorac Surg. 2018 Mar 9. pii: S0003-4975(18)30327.
    Abstract    

    Abstract available

  87. FERNANDES CJ, Steigner ML, Piazza G, Goldhaber SZ, et al
    Collaborative Cardiology and Pulmonary Management of Pulmonary Hypertension.
    Chest. 2019;156:200-202.
    Abstract    



  88. KING CS, Nathan SD
    Pulmonary hypertension due to interstitial lung disease.
    Curr Opin Pulm Med. 2019;25:459-467.
    Abstract    

    Abstract available

  89. KOVACS G, Olschewski H
    Debating the new haemodynamic definition of pulmonary hypertension: much ado about nothing?
    Eur Respir J. 2019;54.
    Abstract    



  90. MARTIN AK, Renew JR, Jayaraman AL, Murray AW, et al
    Analysis of Outcomes in Lung Transplantation.
    J Cardiothorac Vasc Anesth. 2018 Jul 17. pii: S1053-0770(18)30404.
    Abstract    



  91. LIU J, Thakrar M
    Predicting survival for non-operative chronic thromboembolic pulmonary hypertension: Practice can make perfect.
    J Heart Lung Transplant. 2019;38:843-844.
    Abstract    




Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;